文献速递炎症性肠病消化道肿瘤与早癌消化内镜

监测质量影响结肠炎相关进展期肿瘤风险:一项多中心病例对照研究

Quality of Surveillance Impacts the Colitis-Associated Advanced Neoplasia Risk: A Multicenter Case-Control Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-12-23

该多中心病例对照研究利用荷兰全国病理数据库,纳入137例进展期肿瘤病例和138例对照,评估监测结肠镜质量指标与进展期肿瘤风险的关系。结果显示,延迟监测间隔和活动性炎症与进展期肿瘤风险升高相关,而符合主要质量指标的监测与风险降低相关,色素内镜检查亦与风险降低相关。

要点

  • 延迟监测间隔与进展期肿瘤风险升高相关(aOR 2.00,95%CI 1.07-3.81,P=0.03)。
  • 活动性炎症与进展期肿瘤风险升高相关(aOR 2.46,95%CI 1.33-4.61,P<0.01)。
  • 符合主要质量指标的监测与进展期肿瘤风险降低相关(aOR 0.43,95%CI 0.22-0.91,P=0.03)。

核心结论

  • 符合主要质量指标的监测与结肠炎相关进展期肿瘤风险降低相关。
  • 延迟监测间隔和活动性炎症与进展期肿瘤风险升高相关,强调包括内镜下缓解在内的操作质量对优化内镜监测效果的重要性。

研究设计与样本

  • 多中心病例对照研究,检索荷兰全国病理数据库,纳入137例进展期肿瘤病例和138例不确定或低级别上皮内瘤变对照。
  • 利用索引病灶(首次不确定上皮内瘤变/低级别上皮内瘤变或进展期肿瘤)之前的监测结肠镜评估监测质量的影响。
  • 采用Firth校正的多变量逻辑回归分析质量指标与进展期肿瘤风险的关联。

主要发现

  • 延迟监测间隔在病例组为58.2%、对照组为39.6%,与进展期肿瘤风险升高相关(aOR 2.00,95%CI 1.07-3.81,P=0.03)。
  • 活动性炎症在病例组为65.3%、对照组为41.8%,与进展期肿瘤风险升高相关(aOR 2.46,95%CI 1.33-4.61,P<0.01)。
  • 符合主要质量指标的监测与进展期肿瘤风险降低相关(aOR 0.43,95%CI 0.22-0.91,P=0.03),色素内镜检查亦与风险降低相关(OR 0.11,95%CI 0.01-0.89,P=0.01)。
  • 其他指标与进展期肿瘤无显著关联。

关键数值与推荐

  • 主要质量指标包括监测间隔、肠道准备、盲肠插管和炎症缺失。
  • 其他评估指标包括色素内镜、内镜医师专业水平、医院设置和活检策略。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Although colorectal cancer (CRC) surveillance is embedded in clinical inflammatory bowel disease (IBD) practice, a subset of patients still develops advanced neoplasia (AN) (high-grade dysplasia [HGD] and/or CRC). We aimed to assess the impact of surveillance quality on AN risk in IBD. METHODS: In this multicenter case-control study, we searched the Dutch nationwide pathology databank to identify IBD cases with AN and controls with indefinite or low-grade dysplasia. The surveillance colonoscopy preceding the index lesion (first indefinite for dysplasia [IND]/low-grade dysplasia [LGD] or AN) was used to assess the impact of surveillance quality. We assessed intervals, bowel preparation, cecal intubation, and absence of inflammation as primary quality indicators. In addition, we assessed chromoendoscopy, endoscopist expertise, hospital setting, and biopsy strategy. Associations of quality indicators with AN risk were determined with multivariable logistic regression analyses with Firth's correction. RESULTS: We included 137 cases and 138 controls. Delayed intervals (58.2% vs 39.6%) and active inflammation (65.3% vs 41.8%) were frequently present in cases and controls and were associated with AN (delayed interval: adjusted odds ratio [aOR], 2.00; 95% confidence interval [CI], 1.07-3.81; P = .03; active inflammation: aOR, 2.46; 95% CI, 1.33-4.61; P < .01). Surveillance compliant with primary quality indicators was associated with a reduced AN risk (aOR, 0.43; 95% CI, 0.22-0.91; P = .03), similar to chromoendoscopy (OR, 0.11; 95% CI, 0.01-0.89; P = .01). Other indicators were not significantly associated with AN. CONCLUSIONS: Surveillance compliant with primary quality indicators is associated with a reduced colitis-associated AN risk. Delayed surveillance intervals and active inflammation were associated with an increased AN risk. This underlines the importance of procedural quality, including endoscopic remission to optimize the effectiveness of endoscopic surveillance.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Te Groen M, Derks M, den Broeder N, et al. Quality of Surveillance Impacts the Colitis-Associated Advanced Neoplasia Risk: A Multicenter Case-Control Study. Clin Gastroenterol Hepatol. 2022. PMID: 36572110. doi:10.1016/j.cgh.2022.12.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。